Hillhurst Biopharmaceuticals, Inc. — Form D

Hillhurst Biopharmaceuticals, Inc. of MONTROSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-26. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-09-26
• Form: D
• Accession: 0001994336-23-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.8M
• Amount sold: $1.8M
• Investors: 10
• Date of first sale: 2023-09-11
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-493089

Issuer

• Name: Hillhurst Biopharmaceuticals, Inc.
• CIK: 0001994336
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2029 VERDUGO BOULEVARD, #125, MONTROSE, CA, 91020
• Phone: (818) 445-5890

Officers, directors & promoters (5)

More

• CIK 1994336 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search